As filed with the Securities and Exchange Commission on January 28, 2026 Registration No. 333-292964 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Akanda Corp. (Exact name of Registrant as specified in its charter) (Primary Standard Industrial Classification Code Number) Ontario, Canada 2833 Not Applicable (I.R.S. Employer Identification No.) Akanda Corp. c/o Gowling WLG (Canada) LLP 100 King St. W, ...

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting As filed with the Securities and Exchange Commission on January 26, 2026 Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Akanda Corp. c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada Tel: +1 (4 ...

Core Viewpoint - Akanda Corp. has successfully closed a transaction with institutional investors for the purchase and sale of 12-month convertible promissory notes totaling $7.0 million in a private placement transaction [1] Group 1: Transaction Details - The proceeds from the sale of the notes will be allocated as follows: up to $2.3 million for marketing purposes, approximately $2.6 million for working capital and general corporate purposes, and up to $2.1 million for debt repayment [2] - Univest Securities, LLC served as the exclusive placement agent for this offering, while Ruskin Moscou Faltischek PC acted as transaction and securities counsel to the Company [2] Group 2: Regulatory Information - The notes and the common shares that can be issued upon conversion have not been registered under the Securities Act of 1933 or any state securities laws, and they cannot be offered or sold in the U.S. or any state without registration or an applicable exemption [3] - Additional details regarding the notes and the transaction can be found in the Company's Form 6-K, filed on January 20, 2026, with the U.S. Securities and Exchange Commission [4]

Core Viewpoint - Akanda Corp. supports potential changes in US federal cannabis policy, including the rescheduling of cannabis from Schedule I to Schedule III, which would recognize its medical value and lower abuse potential [1]. Group 1: Company Position - Interim CEO Katie Field emphasizes the need for modernization of cannabis policies, advocating for a science-led, public-health framework that could enhance medical research and consumer safety [2]. - Akanda encourages policymakers to focus on measurable outcomes such as expanding medical research and protecting public health while moving consumers away from illicit supply chains [3]. Group 2: Industry Context - The proposed changes in US cannabis policy reflect a similar approach to Canada's Cannabis Act, which established a comprehensive legal framework for cannabis, promoting responsible regulation and public health protections [2]. - The shift in policy could help align federal and state laws in the US, creating standards for responsible legal markets [2]. Group 3: Company Overview - Akanda Corp. is dedicated to cultivating and distributing high-quality cannabis and wellness products, aiming to provide safe and accessible cannabis products globally while promoting sustainable business practices [4].

Core Viewpoint - Akanda Corp. is transitioning from being a competitor in Mexico's telecom upgrade to a dominant player that other companies must rely on [1] Company Summary - Akanda Corp. is now positioning itself as a key landlord in the telecom sector, indicating a shift in its operational strategy [1]

Core Insights - Akanda Corp is researching security requirements for a full cultivation license through its cannabis operating subsidiary, aiming to transition from a hemp cultivation license to a full cultivation license for THC products [1][2] - The company has extended its option on its British Columbia asset for an additional two years, focusing on developing THC and CBD assets while implementing Health Canada-compliant security measures [1][2] - Analysts project that Canada's legal cannabis market will grow from approximately USD $3.25–$3.61 billion in 2024 to about USD $5.8–$7.2 billion by 2030, indicating a compound annual growth rate (CAGR) of 10–12% [3] Company Developments - Akanda plans to design and build security measures that include enhanced perimeter controls, access management, continuous surveillance, and secure storage to support future licensing inspections [1][2] - The company aims to achieve specific milestones related to THC cultivation, product sales, and CBD cultivation, with the completion of security infrastructure being a key enabler for these milestones [2] Market Outlook - The anticipated growth in the Canadian cannabis market presents a significant opportunity for Akanda to leverage its planned security and operational readiness to capture market share [3]

Core Insights - Long-term investors perceive proof as a significant milestone, but it is fundamentally a source of pressure [1] Group 1 - The concept of proof in investment is discussed as a critical factor influencing investor sentiment [1]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Artiva Biotherapeutics, Inc. (ARTV) has increased by 124% to $6.22 [3] - Akanda Corp. (AKAN) is up 39% at $3.10 [3] - Kezar Life Sciences, Inc. (KZR) has risen 38% to $5.80 [3] - Carbon Revolution Public Limited Company (CREV) is also up 38% at $5.15 [3] - Safe & Green Holdings Corp. (SGBX) has increased by 28% to $3.96 [3] - Achieve Life Sciences, Inc. (ACHV) is up 23% at $3.80 [3] - Revolution Medicines, Inc. (RVMD) has risen 8% to $53.90 [3] - Erayak Power Solution Group Inc. (RAYA) is up 8% at $5.76 [3] - ProQR Therapeutics N.V. (PRQR) has increased by 7% to $3.00 [3] - Bio Green Med Solution, Inc. (BGMS) is up 6% at $4.04 [3] Premarket Losers - American Rebel Holdings, Inc. (AREB) has decreased by 41% to $2.09 [4] - Sadot Group Inc. (SDOT) is down 25% at $5.35 [4] - AVITA Medical, Inc. (RCEL) has fallen 24% to $4.04 [4] - Soluna Holdings, Inc. (SLNH) is down 23% at $3.22 [4] - American Battery Technology Company (ABAT) has decreased by 17% to $4.70 [4] - CID HoldCo, Inc. (DAIC) is down 17% at $2.16 [4] - Pinnacle Food Group Limited (PFAI) has fallen 12% to $3.12 [4] - OnKure Therapeutics, Inc. (OKUR) is down 12% at $2.52 [4] - Whitehawk Therapeutics, Inc. (WHWK) has decreased by 12% to $2.29 [4] - Aqua Metals, Inc. (AQMS) is down 7% at $14.50 [4]

Core Viewpoint - Scarcity is often perceived negatively in business, with many companies viewing it as a disadvantage [1] Group 1 - Companies typically treat scarcity as a handicap rather than an opportunity [1]

Core Viewpoint - Akanda Corp. is initiating a significant expansion of its telecommunications infrastructure in Mexico by constructing or acquiring up to 20 new cellular towers by the end of 2025, aimed at enhancing network capacity and generating recurring revenue [1][2][3] Company Overview - First Towers & Fiber Corp. (FTF), a wholly-owned subsidiary of Akanda, currently operates 30 revenue-generating towers and a 700-kilometer dark fiber network, positioning itself as a key player in Mexico's telecommunications sector [2][4] - The expansion of the tower network is part of FTF's growth strategy, expected to strengthen connectivity and increase recurring revenue, while reinforcing partnerships with national carriers [3] Strategic Importance - The initiative is aligned with the increasing demand for mobile data and enterprise connectivity solutions in Mexico, ensuring long-term value creation for shareholders [3] - By investing in telecommunications infrastructure, the company aims to support Mexico's digital growth trajectory and the nationwide push for improved connectivity [3]